These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33439775)

  • 1. Global changes to HepG2 cell metabolism in response to galactose treatment.
    Skolik RA; Solocinski J; Konkle ME; Chakraborty N; Menze MA
    Am J Physiol Cell Physiol; 2021 May; 320(5):C778-C793. PubMed ID: 33439775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SR4 Uncouples Mitochondrial Oxidative Phosphorylation, Modulates AMP-dependent Kinase (AMPK)-Mammalian Target of Rapamycin (mTOR) Signaling, and Inhibits Proliferation of HepG2 Hepatocarcinoma Cells.
    Figarola JL; Singhal J; Tompkins JD; Rogers GW; Warden C; Horne D; Riggs AD; Awasthi S; Singhal SS
    J Biol Chem; 2015 Dec; 290(51):30321-41. PubMed ID: 26534958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model.
    Komulainen T; Lodge T; Hinttala R; Bolszak M; Pietilä M; Koivunen P; Hakkola J; Poulton J; Morten KJ; Uusimaa J
    Toxicology; 2015 May; 331():47-56. PubMed ID: 25745980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Catenin regulates hepatic mitochondrial function and energy balance in mice.
    Lehwald N; Tao GZ; Jang KY; Papandreou I; Liu B; Liu B; Pysz MA; Willmann JK; Knoefel WT; Denko NC; Sylvester KG
    Gastroenterology; 2012 Sep; 143(3):754-764. PubMed ID: 22684045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
    Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
    Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone-induced changes in mitochondrial proteins contribute to phenotypic alterations in hepatoma cells.
    Cheng ML; Chi LM; Wu PR; Ho HY
    Biochem Pharmacol; 2016 Oct; 117():20-34. PubMed ID: 27501919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of cellular energetics by galactose and pioglitazone.
    Grimm D; Altamirano L; Paudel S; Welker L; Konkle ME; Chakraborty N; Menze MA
    Cell Tissue Res; 2017 Sep; 369(3):641-646. PubMed ID: 28776185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Galactose Be Converted to Glucose in HepG2 Cells? Improving the
    Xu Q; Liu L; Vu H; Kuhls M; Aslamkhan AG; Liaw A; Yu Y; Kaczor A; Ruth M; Wei C; Imredy J; Lebron J; Pearson K; Gonzalez R; Mitra K; Sistare FD
    Chem Res Toxicol; 2019 Aug; 32(8):1528-1544. PubMed ID: 31271030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor Factor 1.
    Domenis R; Bisetto E; Rossi D; Comelli M; Mavelli I
    Int J Mol Sci; 2012; 13(2):1933-1950. PubMed ID: 22408432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rewiring carbohydrate catabolism differentially affects survival of pancreatic cancer cell lines with diverse metabolic profiles.
    Tataranni T; Agriesti F; Ruggieri V; Mazzoccoli C; Simeon V; Laurenzana I; Scrima R; Pazienza V; Capitanio N; Piccoli C
    Oncotarget; 2017 Jun; 8(25):41265-41281. PubMed ID: 28476035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of oxidative phosphorylation increases the toxicity of SYD-1 on hepatocarcinoma cells (HepG2).
    Brandt AP; Gozzi GJ; Pires Ado R; Martinez GR; Dos Santos Canuto AV; Echevarria A; Di Pietro A; Cadena SM
    Chem Biol Interact; 2016 Aug; 256():154-60. PubMed ID: 27417255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neglected foodborne mycotoxin Fusaric acid induces bioenergetic adaptations by switching energy metabolism from mitochondrial processes to glycolysis in a human liver (HepG2) cell line.
    Sheik Abdul N; Nagiah S; Chuturgoon AA
    Toxicol Lett; 2020 Jan; 318():74-85. PubMed ID: 31654802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.
    Cassim S; Raymond VA; Dehbidi-Assadzadeh L; Lapierre P; Bilodeau M
    Cell Cycle; 2018; 17(7):903-916. PubMed ID: 29633904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic profiling of normal hepatocyte and hepatocellular carcinoma cells via
    Chen Y; Chen Z; Feng JH; Chen YB; Liao NS; Su Y; Zou CY
    Cell Biol Int; 2018 Apr; 42(4):425-434. PubMed ID: 29144590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of Glucotoxicity, Oxidative Stress, Apoptosis and Mitochondrial Dysfunction in HepG2 Cells by Palmitic Acid.
    Alnahdi A; John A; Raza H
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31443411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
    Fan T; Rong Z; Dong J; Li J; Wang K; Wang X; Li H; Chen J; Wang F; Wang J; Wang A
    Cancer Med; 2017 Oct; 6(10):2370-2384. PubMed ID: 28941178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
    Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial UQCC3 Modulates Hypoxia Adaptation by Orchestrating OXPHOS and Glycolysis in Hepatocellular Carcinoma.
    Yang Y; Zhang G; Guo F; Li Q; Luo H; Shu Y; Shen Y; Gan J; Xu L; Yang H
    Cell Rep; 2020 Nov; 33(5):108340. PubMed ID: 33147459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MITOsym®: A Mechanistic, Mathematical Model of Hepatocellular Respiration and Bioenergetics.
    Yang Y; Nadanaciva S; Will Y; Woodhead JL; Howell BA; Watkins PB; Siler SQ
    Pharm Res; 2015 Jun; 32(6):1975-92. PubMed ID: 25504454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2.
    Shen M; Xu M; Zhong F; Crist MC; Prior AB; Yang K; Allaire DM; Choueiry F; Zhu J; Shi H
    Cells; 2021 Feb; 10(2):. PubMed ID: 33672651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.